In Part 1 and Part 2, we covered how to calculate your cardiovascular risk in the Cardiovascular-Kidney-Metabolic (CKM) framework and what markers and risk factors to measure. In Part 3 (#70) of this ...

The MarketWatch News Department was not involved in the creation of this content.-- Study assessing PharmaSens all-in-one insulin patch pump provides first evidence that combining ...

Background Diabetic foot is an infection, ulceration or destruction of the tissue of the foot of a person diagnosed with diabetes mellitus (DM). Diabetic foot ulcer (DFU) is a major and preventable ...

New recommendations suggest that some people should start trying to lower their cholesterol as early as age 30.

UC Way Hypertension Medication Algorithm improved blood pressure control from 68.5% to nearly 74% among 90,000 patients ...

Amarin Corporation plc (NASDAQ: AMRN) ("Amarin"), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today highlighted the important scientific and educational ...

Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today highlighted the important scientific and educational ...

The Lancet obesity framework aims to improve risk assessment but risks delaying treatment and deepening health inequities, according to recent evaluations.

Read more from STAT contributor Brianna Abbott on the popular vote winner. And STAT’s Amanda Erickson, who edits this very newsletter, has a dispatch on the research our editors chose as the best ...

Monitoring your cholesterol levels is one thing you can do to keep your heart healthy and stave off your risk of heart ...

A new algorithm designed to consider all forms of diabetes when diagnosing patients is among the additions in the American ...

As patents on semaglutide expire, manufacturers are poised to introduce cheaper generic versions of blockbuster drugs, with far-reaching effects on the obesity crisis. Megan Tatum reports.